Andukuri A, Sohn YD, Anakwenze C, Lim DJ, Brott B, Yoon YS, Jun HW. Enhanced human endothelial progenitor cell adhesion and differentiation by a bioinspired multifunctional nanomatrix. Tissue Eng Part C Methods. 2012 Dec 19. [Epub ahead of print]

Moon SH, Ban K, Kim C, Kim SS, Byun J, Song MK, Park IH, Yu SP, Yoon YS. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells. Int J Cardiol. 2012 Oct 5 [Epub ahead of print]

Sohn YD, Han JW, Yoon YS. Generation of induced pluripotent stem cells from somatic cells. Prog Mol Biol Transl Sci. 2012;111:1-26

Lee S, Yoon YS. Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells. Br J Pharmacol. 2012 Jan 17 [Epub ahead of print]

Kim H, Kim JJ, Yoon YS. Emerging therapy for diabetic neuropathy: Cell therapy targeting vessels and nerves. Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):168-78

Upadhyay AK, Rotili D, Han JW, Hu R, Chang Y, Labella D, Zhang X, Yoon YS, Mai A, Cheng X. An Analog of BIX-01294 Selectively Inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases. J Mol Biol. 2012 Feb 24;416(3):319-27

Han JW, Yoon YS. Epigenetic Landscape of Pluripotent Stem Cells. Antioxid Redox Signal. 2012 Jul 15;17(2):205-23 (Journal Cover)

Park C, Lee JY, Yoon YS. Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization.Trends Cardiovasc Med. 2011 Jul;21(5):135-40 (Journal Cover)

Hodara R, Weiss D, Joseph G, Velasquez-Castano JC, Landázuri N, Han JW, Yoon YS, Taylor WR. Over-expression of catalase in myeloid cells causes impaired post-ischemic neovascularization. Arterioscler Thromb Vasc Biol. 2011;31:2203-9

Szulwach KE, Li X, Li Y, Song CX, Han JW, Kim S, Namburi S, Hermetz K, Kim JJ, Rudd MK, Yoon YS, Ren B, He C, Jin P. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 2011;7:e1002154.

Kim SW, Kim H, Yoon YS. Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med. 2011;3:335-49.

Jeong JO, Han JW, Kim JM, Cho HJ, Park CW, Lee NH, Kim DW, Yoon YS. Malignant Tumor Formation After Transplantation of Short-Term Cultured Bone Marrow Mesenchymal Stem Cells in Experimental Myocardial Infarction and Diabetic Neuropathy.Circ Res. 2011;108:1340-7.

Han JW, Yoon YS. Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming. Antioxid Redox Signal.2011;15:1799-1820 (Journal Cover)

Kishore R, Tkebuchava T, Sasi SP, Silver M, Gilbert HY, Yoon YS, Park HY, Thorne T, Losordo DW, Goukassian DA. Tumor Necrosis Factor-α Signaling via TNFR1/p55 Is Deleterious Whereas TNFR2/p75 Signaling Is Protective in Adult Infarct Myocardium. Adv Exp Med Biol. 2011;691:433-48

Andukuri A, Kushwaha M, Tambralli A, Anderson JM, Dean DR, Berry JL, Sohn YD, Yoon YS, Brott BC, Jun HW. A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants. Acta Biomater. 2011;7:225-233

Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P, Yun SH, Yoon YS. Podoplanin-Expressing Cells Derived From Bone Marrow Play a Crucial Role in Postnatal Lymphatic Neovascularization. Circulation. 2010;122:1413-1425

Sen S, Merchan JA, Dean J, Ii M, Gavin M, Silver M, Tkebuchava T, Yoon YS, Rasko JE, Aikawa R. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering igf-1 gene following myocardial infarction. Hum Gene Ther. 2010;21:1327-1334

Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, Sohn YD, Lee MY, Houge MA, Yoon YS. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow. Novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res. 2010;107:602-614

Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon YS. Human peripheral blood-derived CD31(+) cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol. 2010;56:593-607

Kim SW, Yoon YS. True autologous approach in cell therapy. – Using your own serum for cell culture. Circ J. 2010;74:852-853

Kim H, Kim SW, Nam D, Kim S, Yoon YS. Cell therapy with bone marrow cells for myocardial regeneration. Antioxid Redox Signal. 2009;11:1897-1911

Kim H, Park JS, Choi YJ, Kim MO, Huh YH, Kim SW, Han JW, Lee J, Kim S, Houge MA, Ii M, Yoon YS. Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells. 2009;27:1686-1696

Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, Lee JU, Lee J, Choi YJ, Cho HJ, Lee N, Silver M, Wecker A, Kim DW, Yoon YS. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation.2009;119:699-708

Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, Taylor WR, Yoon YS, Jo H. Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol.2008;28:1989-1995

Kirchmair R, Tietz AB, Panagiotou E, Walter DH, Silver M, Yoon YS, Schratzberger P, Weber A, Kusano K, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: Taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF. Mol Ther. 2007;15:69-75

Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, Yoon YS. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med. 2007;204:3257-3269

Qin G, Ii M, Silver M, Wecker A, Bord E, Ma H, Gavin M, Goukassian DA, Yoon YS, Papayannopoulou T, Asahara T, Kearney M, Thorne T, Curry C, Eaton L, Heyd L, Dinesh D, Kishore R, Zhu Y, Losordo DW. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med. 2006;203:153-163

Lee J, Wecker A, Losordo DW, Yoon YS. Derivation and characterization of bone marrow-derived multipotent stem cells. Exp Hematol. 2006;34:1602-1603

Ii M, Takenaka H, Asai J, Ibusuki K, Mizukami Y, Maruyama K, Yoon YS, Wecker A, Luedemann C, Eaton E, Silver M, Thorne T, Losordo DW. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res. 2006;98:697-704

Cho HJ, Yoon YS. Synergism of hematopoietic cytokines for infarct repair. Circ Res. 2006;98:990-992

Cho HJ, Lee J, Wecker A, Yoon YS. Bone marrow-derived stem cell therapy in ischemic heart disease. Regen Med. 2006;1:337-345

Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, Losordo DW. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005;115:326-338

Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: Restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation. 2005;111:2073-2085

Yoon YS, Lee N, Scadova H. Myocardial regeneration with bone-marrow-derived stem cells. Biol Cell. 2005;97:253-263

Lee N, Thorne T, Losordo DW, Yoon YS. Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cells. Cell Cycle. 2005;4:861-864

Kusano KF, Pola R, Murayama T, Curry C, Kawamoto A, Iwakura A, Shintani S, Ii M, Asai J, Tkebuchava T, Thorne T, Takenaka H, Aikawa R, Goukassian D, von Samson P, Hamada H, Yoon YS, Silver M, Eaton E, Ma H, Heyd L, Kearney M, Munger W, Porter JA, Kishore R, Losordo DW. Sonic hedgehog myocardial gene therapy: Tissue repair through transient reconstitution of embryonic signaling. Nat Med. 2005;11:1197-1204

Kirchmair R, Walter DH, Ii M, Rittig K, Tietz AB, Murayama T, Emanueli C, Silver M, Wecker A, Amant C, Schratzberger P, Yoon YS, Weber A, Panagiotou E, Rosen KM, Bahlmann FH, Adelman LS, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: Attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation. 2005;111:2662-2670

Ii M, Nishimura H, Kusano KF, Qin G, Yoon YS, Wecker A, Asahara T, Losordo DW. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation. 2005;112:93-102

Bosch-Marce M, Pola R, Wecker AB, Silver M, Weber A, Luedemann C, Curry C, Murayama T, Kearney M, Yoon YS, Malinow MR, Asahara T, Isner JM, Losordo DW. Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia. Vasc Med. 2005;10:15-22

Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation. 2004;109:3154-3157

Yoon YS, Johnson IA, Park JS, Diaz L, Losordo DW. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol Cell Biochem. 2004;264:63-74

Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D. Src blockade stabilizes a flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest. 2004;113:885-894

Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, Tietz AB, Kirchmair R, Silver M, Curry C, Wecker A, Yoon YS, Heidenreich R, Hanley A, Kearney M, Tio FO, Kuenzler P, Isner JM, Losordo DW. Local gene transfer of phvegf-2 plasmid by gene-eluting stents: An alternative strategy for inhibition of restenosis. Circulation. 2004;110:36-45

Kusano KF, Allendoerfer KL, Munger W, Pola R, Bosch-Marce M, Kirchmair R, Yoon YS, Curry C, Silver M, Kearney M, Asahara T, Losordo DW. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy.Arterioscler Thromb Vasc Biol. 2004;24:2102-2107

Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. Vegf-c gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003;111:717-725

Yoon YS, Losordo DW. All in the family: Vegf-b joins the ranks of proangiogenic cytokines. Circ Res. 2003;93:87-90

Kwon Koo B, Shim WH, Yoon YS, Kwon Lee B, Choi D, Jang Y, Lee DY, Chang BC. Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with behcet’s disease. J Endovasc Ther. 2003;10:75-80

Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461-468

Goukassian DA, Kishore R, Krasinski K, Dolan C, Luedemann C, Yoon YS, Kearney M, Hanley A, Ma H, Asahara T, Isner JM, Losordo DW. Engineering the response to vascular injury: Divergent effects of deregulated e2f1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth. Circ Res. 2003;93:162-169

Shim WH, Koo BK, Yoon YS, Choi D, Jang Y, Lee DY, Chang BC. Treatment of thoracic aortic dissection with stent-grafts: Midterm results. J Endovasc Ther. 2002;9:817-821

Jee SH, Song KS, Shim W, Kim HK, Suh I, Yoon Y, Beaty TH. Genetic contribution to factor vii levels in families of patients undergoing coronary arteriography. Blood Coagul Fibrinolysis. 2002;13:25-33

Yoon YS, Shim WH, Kim SM, Park KJ, Cho SY. Carotid artery stenting in patients with symptomatic coronary artery disease.Yonsei Med J. 2000;41:89-97

Yoon YS, Shim WH. Transseptal approach for stent implantation in right internal carotid artery stenosis. J Invasive Cardiol.2000;12:70-74

Yoon Y, Shim WH, Lee DH, Pyun WB, Kim IJ, Jang Y, Cho SY. Usefulness of cilostazol versus ticlopidine in coronary artery stenting. Am J Cardiol. 1999;84:1375-1380

Yoon YS, Shim WH, Chung TS, Lee YS. Primary idiopathic chylopericardium: Report of a case and review of the literature. Yonsei Med J. 1993;34:98-108

Yoon YS, Min YH, Chon CY, Park C, Lee SJ, Hahn JS, Ko YW, Choi HJ. Liver involvement in multiple myeloma proven by peritoneoscopy–a case report. Yonsei Med J. 1993;34:90-97

Lim GT, Kim SS, Park SH, Choo WO, Kang DH, Park IS, Chang YS, Yoon YS, Bang BK. Thrombotic thrombocytopenic purpura-like syndrome associated with systemic lupus erythematosus–combined treatment with plasmapheresis and fresh frozen plasma infusion. J Korean Med Sci. 1992;7:66-70